Jie Zhou

5PUBLICATIONS
18CO-AUTHORS
Gene and molecular therapyAutoimmunityMolecular targetsMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 21, 2026
Development of the Weight-Tiered Q3W Regimen of Amivantamab in Combination With Carboplatin-Pemetrexed in EGFR-Mutated Non-Small Cell Lung Cancer.

|May 13, 2026
Talquetamab: Mechanism of Action, Clinical, and Translational Science.

|Apr 15, 2023
Model-Based Investigation of Inadequate Efficacy of Tesnatilimab, an Anti-Natural Killer Group 2 Member D Monoclonal Antibody, in Moderately to Severely Active Crohn Disease.

Jie Zhou, Yan Xu, Yang Chen

|Jul 17, 2022
Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced Cancer.

Mingxiang Liao, Jie Zhou, Kenton Wride

|May 08, 2020
The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19.

Virginia D Schmith, Jie Jessie Zhou, Lauren R L Lohmer

Pageof 1

Frequent Collaborators

2 joint publications

Dongfen Yuan

2 joint publications

Nahor Haddish-Berhane

1 joint publications

Virginia D Schmith

1 joint publications

Lauren R L Lohmer